Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
These countries contributed $139,492.2 million to the global generics industry in 2022, with a compound annual growth rate (CAGR) of 12.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $210,704.1 million in 2027, with a CAGR of 8.6% over the 2022-27 period.
Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $111,666.9 million in 2022. This was followed by India and Mexico with a value of $17,617.5 and $6,036.8 million, respectively.
China is expected to lead the generics industry in the top five emerging nations, with a value of $171,144.4 million in 2027, followed by India and Mexico with expected values of $26,308.6 and $7,402.3 million, respectively.
Scope
Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
What was the size of the emerging five generics market by value in 2022?
What will be the size of the emerging five generics market in 2027?
What factors are affecting the strength of competition in the emerging five generics market?
How has the market performed over the last five years?
How large is the emerging five generics market in relation to its regional counterparts?
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Generics
2.1. Industry Outlook
3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Aspen Pharmacare Holdings Ltd
13.2. Teva Pharmaceutical Industries Limited
13.3. Adcock Ingram Holdings Ltd
13.4. Novartis AG
13.5. Sanofi SA
13.6. EMS SA
13.7. Ache Laboratorios Farmaceuticos SA
13.8. Eurofarma Laboratorios SA
13.9. Viatris Inc.
13.10. Pfizer Inc.
13.11. Grand Pharmaceutical Group Limited
13.12. Lupin Ltd
13.13. Cipla Limited
13.14. Sun Pharmaceutical Industries Ltd
13.15. Aurobindo Pharma Ltd
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2018-27
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2018-22
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2022-27
Table 4: South Africa generics market value: $ million, 2017-22
Table 5: South Africa generics market volume: %, 2017-22
Table 6: South Africa generics market geography segmentation: $ million, 2022
Table 7: South Africa generics market value forecast: $ million, 2022-27
Table 8: South Africa generics market volume forecast: %, 2022-27
Table 9: South Africa size of population (million), 2018-22
Table 10: South Africa gdp (constant 2005 prices, $ billion), 2018-22
Table 11: South Africa gdp (current prices, $ billion), 2018-22
Table 12: South Africa inflation, 2018-22
Table 13: South Africa consumer price index (absolute), 2018-22
Table 14: South Africa exchange rate, 2018-22
Table 15: Brazil generics market value: $ million, 2017-22
Table 16: Brazil generics market volume: %, 2017-22
Table 17: Brazil generics market geography segmentation: $ million, 2022
Table 18: Brazil generics market value forecast: $ million, 2022-27
Table 19: Brazil generics market volume forecast: %, 2022-27
Table 20: Brazil size of population (million), 2018-22
Table 21: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 22: Brazil gdp (current prices, $ billion), 2018-22
Table 23: Brazil inflation, 2018-22
Table 24: Brazil consumer price index (absolute), 2018-22
Table 25: Brazil exchange rate, 2018-22
Table 26: China generics market value: $ million, 2017-22
Table 27: China generics market volume: %, 2017-22
Table 28: China generics market geography segmentation: $ million, 2022
Table 29: China generics market value forecast: $ million, 2022-27
Table 30: China generics market volume forecast: %, 2022-27
Table 31: China size of population (million), 2018-22
Table 32: China gdp (constant 2005 prices, $ billion), 2018-22
Table 33: China gdp (current prices, $ billion), 2018-22
Table 34: China inflation, 2018-22
Table 35: China consumer price index (absolute), 2018-22
Table 36: China exchange rate, 2018-22
Table 37: India generics market value: $ million, 2017-22
Table 38: India generics market volume: %, 2017-22
Table 39: India generics market geography segmentation: $ million, 2022
Table 40: India generics market value forecast: $ million, 2022-27
Table 41: India generics market volume forecast: %, 2022-27
Table 42: India size of population (million), 2018-22
Table 43: India gdp (constant 2005 prices, $ billion), 2018-22
Table 44: India gdp (current prices, $ billion), 2018-22
Table 45: India inflation, 2018-22
Table 46: India consumer price index (absolute), 2018-22